2,229
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The aptamer–siRNA conjugates: Reprogramming T Cells for Cancer Therapy

, &
Pages 1-4 | Published online: 07 Jan 2015
 

Disclaimer

The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Financial & competing interests disclosure

The authors’ work was supported in part by the NCI/NIH award (R01CA155367), a Department of Defense Prostate Cancer Program grant (W81XWH-12-1-0132) and a V Foundation Translational Research grant (to M Kortylewski). One of the authors (M Kortylewski) is a coinventor on the patent US07951374 and a pending patent application US20120065125. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.